STM2457

CAS No. 2499663-01-1

STM2457 ( —— )

Catalog No. M24139 CAS No. 2499663-01-1

STM2457 is a first-in-class, highly potent, selective and orally active inhibitor of METTL3 . It can be used for the research of acute myeloid leukaemia (AML).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 194 In Stock
10MG 314 In Stock
25MG 521 In Stock
50MG 745 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    STM2457
  • Note
    Research use only, not for human use.
  • Brief Description
    STM2457 is a first-in-class, highly potent, selective and orally active inhibitor of METTL3 . It can be used for the research of acute myeloid leukaemia (AML).
  • Description
    STM2457 is a first-in-class, highly potent, selective and orally active inhibitor of METTL3 . It can be used for the research of acute myeloid leukaemia (AML).
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    METTL3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2499663-01-1
  • Formula Weight
    444.5
  • Molecular Formula
    C25H28N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (281.20 mM; Need ultrasonic)
  • SMILES
    O=C(C(N=C1N2C=CC=C1)=CC2=O)NCC3=CN4C=C(CNCC5CCCCC5)C=CC4=N3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wesley Peter Blackaby, et al. Mettl3 inhibitory compounds. WO2020201773A1.
molnova catalog
related products
  • 3,5-dimethyl-4-pheny...

    3,5-dimethyl-4-phenyl-1,2-oxazole is a compound used as a molecular building block.

  • N-Boc-PEG5-bromide

    N-Boc-PEG5-bromide is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-PEG5-bromide is a PROTAC linker based on PEG and Alkyl/ether.

  • C-telopeptide

    C-telopeptide, a cross-linked peptide of type I collagen, is released during bone resorption and has been correlated with bone mineral density (BMD).